CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets

Yuying Zhang1, Jingyan Luo2, Weikang Yang3

  • 1Central Laboratory, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, 518109, China.

PubMed

Insights

Circular RNAs (circRNAs) show abnormal expression in colorectal cancer (CRC) and are crucial to its development. These molecules offer potential for CRC diagnosis, prognosis, and targeted therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a major global health concern, ranking third in prevalence and second in cancer mortality.
  • Circular RNAs (circRNAs) are stable, conserved RNA molecules with abnormal expression detected in various CRC patient samples.
  • Emerging evidence highlights the critical role of circRNAs in CRC development and progression.

Purpose of the Study:

  • To review current research on the function of circRNAs in colorectal cancer.
  • To explore the potential of circRNAs as biomarkers for CRC diagnosis and prognosis.
  • To discuss the application of circRNAs in targeted CRC therapy.

Main Methods:

  • Literature review of recent studies on circRNAs and CRC.
  • Analysis of circRNA functions, including microRNA and protein sponge activities.
  • Examination of circRNAs' roles in gene regulation and translation.

Main Results:

  • Abnormal circRNA expression is a hallmark of CRC across different sample types.
  • CircRNAs participate in CRC pathogenesis through diverse molecular mechanisms.
  • CircRNAs demonstrate significant potential as diagnostic and prognostic markers for CRC.

Conclusions:

  • CircRNAs are pivotal in colorectal cancer development and progression.
  • CircRNAs hold promise for novel diagnostic and therapeutic strategies in CRC.
  • Further research is essential to fully elucidate circRNA mechanisms and clinical applications in CRC.